Annis Gardner Whiting Capital Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,083
Closed -$27.4K 1304
2025
Q2
$27.4K Buy
+1,083
New +$26.9K 0.01% 507

Other funds holding IBDX

Annis Gardner Whiting Capital Advisors's IBDX Position: Q3 2025 in Review

Annis Gardner Whiting Capital Advisors sold out of iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q3 2025, closing a stake of 1,083 shares — an estimated $27.4K sold.

Annis Gardner Whiting Capital Advisors first reported a position in IBDX in Q2 2025 and held it in 1 quarter. The position peaked at $27.4K in Q2 2025. 176 funds tracked by Wall St. Rank hold IBDX as of Q3 2025.

  • Annis Gardner Whiting Capital Advisors reported no remaining iShares iBonds Dec 2032 Term Corporate ETF position as of Q3 2025 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 1,083 iShares iBonds Dec 2032 Term Corporate ETF shares in Q3 2025, an estimated $27.4K.
  • Annis Gardner Whiting Capital Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2025 and held it in 1 quarter.
  • Annis Gardner Whiting Capital Advisors's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $27.4K in Q2 2025.
  • 176 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q3 2025.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.